Table 1.
Method | Year | Data | Class Groups | Results |
---|---|---|---|---|
Statistical approach [9] | 2021 | Plasma and single-cell proteomic | Mild, moderate, severe | AUCtraining = 0.799 AUCvalidation = 0.773 |
Deep Learning [10] | 2022 | CXR | COVID-19 and normal | Mean absolute error of 0.30 |
Deep Learning [11] | 2021 | CXR | Severity level (scores from 0 to 8) | confusion matrix: Sensitivity = 0.94 Specificity = 0.98 |
Deep learning [12] ResNet |
2022 | CXR | COVID-19, virus, bacteria, ARDS, SARS, Streptococcus, normal | Accuracy = 98% |
Deep learning [13] | 2023 | CXR | COVID-19, virus, bacteria, and normal | Accuracy = 97.65% |
Deep learning [14] CORONA-NET | 2023 | CXR | COVID-19, viral pneumonia, normal | Accuracy = 99.57% |
Deep learning [15] ResNet |
2023 | CXR | COVID-19, non-COVID-19, and normal | Accuracy = 96% |
Deep learning [16] DAM-Net | 2023 | CXR | COVID-19, pneumonia, and normal | Accuracy = 97.22% Sensitivity = 96.87% Specificity = 99.12% |
Deep learning [17] | 2021 | CXR | Severity descriptors vs. radiologist’s severity ratings, normal vs. abnormal |
Correlation = 0.68 (p < 0.0001) AUC = 0.78 |
Cytokine profiles with statistical approaches [20] | 2022 | Cytokine concentration | Severe, moderate, and mild | AUC = 0.83 |
Supervised machine learning models [21] | 2023 | Feature-dataset consisting of the routine blood values and demographic data that affect the prognosis of COVID-19 | Severely and mildly | AUC range: 0.75 to 0.95 Accuracy range: 94.05% to 97.86% |
Vision Transformers [22] | 2022 | CXR and CT | COVID-19, pneumonia, and normal | Accuracy = 94.62% |
COVID_SDNet [23] | 2020 | CXR | Severe, moderate, and mild | Accuracy = 81.0% ± 2.9% Sensitivity = 76.8% ± 6.3% Specificity = 85.2% ± 5.4% |
Multi-task vision [18] | 2022 | CXR | Severity degree from 0 to 6 | Accuracy range: 78.7% to 97.7% |
Multi-stage framework [19] | 2023 | CXR | Mild, moderate, severe, and critical | Accuracy = 97.63% |